| When | Apr 29, 2021 from 10:30 AM to 06:20 PM |
|---|---|
| Where | Online via Zoom |
| Contact Name | Vicky Reid |
| Attendees | 140 |
| Add event to calendar |  vCal iCal |
THURSDAY 29 APRIL 2021
PLEASE REGISTER ON EVENTBRITE TO ENSURE YOU RECEIVE THE EVENT LINK NEAR THE TIME
REGISTRATION ON EVENTBRITE
CALL FOR POSTERS
DOWNLOAD POSTER ABSTRACT SUBMISSION FORM (deadline Fri 26 Feb)
10.30- 11.30 Abstracts open and poster presentations
12.00 – 12.10 Martin Bennett – Overview and progress of the CRE
SESSION 1 Population and Data Science (Chair John Danesh)
12.10 – 12.25 Emanuele Di Angelantonio, Cardiovascular disease risk prediction using UK Biobank TBC
12.25– 12.40 Lisa Pennells, New developments in Cardiovascular disease risk scores
12.40 – 12.55 Praveen Surendran, Genetic study molecular phenotypes to understand complex disease aetiology
SESSION 2 Functional Genomics (Chair Nicole Soranzo)
13.00 – 13.15 Seamus Harrison, Genomics of aortic diseases
13.15 – 13.30 Stefan Graf, Update on PAH genomics
13.30 – 13.45 Alex Granata, Modelling stroke using iPSCs
SESSION 3 Cardiometabolic Medicine (Chair Toni Vidal-Puig)
13.50 – 14.05 Claudia Langenberg, Plasma protein patterns as comprehensive indicators of health
14.05 – 14.20 Dino Giussani, Heart Disease Link to Fetal Hypoxia
14.20 – 14.35 Ana Vujic, Benefits of Physical Exercise on the Aging heart
14.40-15.00 Break, Refreshments
SESSION 4 Cardiovascular Medicine (Chair Ziad Mallat)
15.00 – 15.15 Jordi Lambert, Heterogeneity in vascular smooth muscle cell activation.
15.15 – 15.30 Xuan Li, Microtubule-dependent mechanism in controlling cardiomyocyte contractility after myocardial infarction
15.30 – 15.45 Maria Colzani– Cardiovascular involvement in COVID-19
SESSION FIVE Translation (Chair Ian Wilkinson)
15.50 – 16.05 Tian Zhao, Low-dose interleukin-2 in patients with ischaemic heart disease
16.05 – 16.20 James Goodman, Cardiovascular Effects of GLP-1 and Glucagon Receptor Dual Agonism – New Insights
16.20 – 16.35 Li-ming Gan (AstraZeneca, Bioscience Cardiovascular) Microvascular inflammation in HFpEF
16.40– 17.20 Keynote speaker: Professor Aroon Hingorani (University College London), Democratising cardiovascular drug development through human genomics
17.20 – 17.30 Closing words and abstract/poster prizes- Martin Bennett
17.30 – 18.30 Networking session in breakout rooms
Document
